Biocryst Pharmaceuticals reported $79.54M in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Adamas Pharmaceuticals ADMS:US 31.13M 2.29M
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
Alnylam Pharmaceuticals ALNY:US $ 366.71M 2.89M
Biocryst Pharmaceuticals BCRX:US $ 79.54M 9.1M
Chemocentryx CCXI:US $ 40.55M 871K
Chugai Pharma 4519:JP 124.7B 19.85B
Daiichi Sankyo 4568:JP 218.3B 31.09B
Enanta Pharmaceuticals ENTA:US $ 55.47M 5.64M
Gilead Sciences GILD:US $ 3971M 438M
Glaxosmithkline GSK:US 6.42B 692M
GlaxoSmithKline GSK:LN 6.42B 692M
Intra Cellular Therapies ITCI:US $ 89.19M 20.09M
IONIS PHARMACEUT IONS:US $ 207.35M 3.77M
Karyopharm Therapeutics KPTI:US $ 71.65M 3.98M
Mirati Therapeutics MRTX:US $ 164.19M 31.76M
Neurocrine Biosciences NBIX:US $ 226.1M 21M
Novavax NVAX:US $ 643.85M 12.01M
Ptc Therapeutics PTCT:US $ 215.17M 921K
Regeneron Pharmaceuticals REGN:US $ 1791.3M 375.3M
Sarepta Therapeutics SRPT:US $ 331.66M 32.87M
Ultragenyx Pharmaceutical RARE:US $ 169.75M 36.21M
Vertex Pharmaceuticals VRTX:US $ 1831.33M 994.85M
YTE INCY:US $ 564.87M 58.95M
Zogenix ZGNX:US $ 74.22M 8.73M